Alan Braverman-Poyastro

Alan Braverman-Poyastro

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ABAlan Braverman-Poyastro
Alan Braverman-Poyastro
BSBlanca Vianey Suarez-Rico
Blanca Vianey Suarez-Rico
HBHector Borboa-Olivares
Hector Borboa-Olivares
Salvador Espino y SosaSalvador Espino y Sosa
Salvador Espino y Sosa
Johnatan TorresJohnatan Torres
Johnatan Torres
EREnrique Reyes-Muñoz
Enrique Reyes-Muñoz
Antepartum fetal surveillance (AFS) is essential for pregnant women with diabetes to mitigate the risk of stillbirth. However, there is still no universal consensus on the optimal testing method, testing frequency, and delivery timing. This review aims to comprehensively analyze the evidence concerning AFS and the most advantageous timing for delivery in both gestational and pregestational diabetes mellitus cases. This review’s methodology involved an extensive literature search encompassing international diabetes guidelines and scientific databases, including PubMed, MEDLINE, Google Scholar, and Scopus. The review process meticulously identified and utilized pertinent articles for analysis. Within the scope of this review, a thorough examination revealed five prominent international guidelines predominantly addressing gestational diabetes. These guidelines discuss the utility and timing of fetal well-being assessments and recommendations for optimal pregnancy resolution timing. However, the scarcity of clinical trials directly focused on this subject led to a reliance on observational studies as the basis for most recommendations. Glucose control, maternal comorbidities, and the medical management received are crucial in making decisions regarding AFS and determining the appropriate delivery timing.